• 동의신경정신과학회지
• /
• 제32권3호
• /
• pp.207-217
• /
• 2021

Objectives: The objective of this study was to perform a scoping review to describe clinical study trends on Qigong in order to identify further directions of Qigong in Korean medicine. Methods: Under the Arksey and O'Malley methodological framework, PubMed was searched to identify articles published from January 1, 2019 to June 28, 2021. A total of 224 articles were retrieved. Results were systematically filtered by two independent reviewers based on inclusion/exclusion criteria. Publication information, disease, intervention and research results of a total of 153 articles were extracted and analyzed. Results: Asia had the largest number of Qigong studies (82 studies, 65%). Most research studies were conducted in the academic field of Medicine (n=109, 86.5%), including Complementary and Alternative Medicine (n=35), Medicine (miscellaneous) (n=15), and Oncology (n=15). Based on ICD-10 classification, Mental and Behavioral Disorder (n=25, 19.8%) was the most frequently analyzed decease, followed by Neoplasm (n=24) and Disease of the Nervous system (n=12). Almost half of all studies were Systematic Reviews. RCTs only accounted for 25.4%. Interventions were very diverse and inconsistent. Sixty (47.6%) studies analyzed Qigong as a single intervention. In 66 cases, Qigong was analyzed as part of a large category such as Mind-Body intervention. Most studies designed a Donggong (動功) program. The age of the population was relatively high as 47.1% of all studies were conducted on middle aged or older adults. Conclusions: These findings suggest that further standardized research on Qigong, especially Junggong (靜功), needs to be conducted by developing research protocols and practice programs to verify effects of Qigong and utilize Qigong as a medical intervention in Korean Medicine.

• Molecules and Cells
• /
• 제42권2호
• /
• pp.143-150
• /
• 2019

Chronic neuropathic pain is one of the primary causes of disability subsequent to spinal cord injury. Patients experiencing neuropathic pain after spinal cord injury suffer from poor quality of life, so complementary therapy is seriously needed. Dehydrocorybulbine is an alkaloid extracted from Corydalis yanhusuo. It effectively alleviates neuropathic pain. In the present study, we explored the effect of dehydrocorybulbine on neuropathic pain after spinal cord injury and delineated its possible mechanism. Experiments were performed in rats to evaluate the contribution of dehydrocorybulbine to P2X4 signaling in the modulation of pain-related behaviors and the levels of pronociceptive interleukins and proteins after spinal cord injury. In a rat contusion injury model, we confirmed that chronic neuropathic pain is present on day 7 after spinal cord injury and P2X4R expression is exacerbated after spinal cord injury. We also found that administration of dehydrocorybulbine by tail vein injection relieved pain behaviors in rat contusion injury models without affecting motor functions. The elevation in the levels of pronociceptive interleukins ($IL-1{\beta}$, IL-18, MMP-9) after spinal cord injury was mitigated by dehydrocorybulbine. Dehydrocorybulbine significantly mitigated the upregulation of P2X4 receptor and reduced ATP-evoked intracellular $Ca^{2+}$ concentration. Both P2XR and dopamine receptor2 agonists antagonized dehydrocorybulbine's antinociceptive effects. In conclusion, we propose that dehydrocorybulbine produces antinociceptive effects in spinal cord injury models by inhibiting P2X4R.

• 한국산학기술학회논문지
• /
• 제21권1호
• /
• pp.477-486
• /
• 2020

본 연구는 알츠하이머 치매노인을 대상으로 Apolipoprotein E (ApoE) ɛ4의 유무와 치매수준에 따른 우울과 기억력의 상관관계를 분석하고자 하였다. 임상치매척도(clinical dementia rating; CDR)가 0.5점에서 2점 사이인 65세 이상 노인 50명을 대상으로 임상치매척도, 노인용 서울언어학습검사, 레이 복합도형검사, 축약형 노인우울검사를 실시하였고 ApoE 유전자형은 구강상피세포를 채취하여 실시한 유전자 검사를 통해 확인하였다. 자료분석은 맨 휘트니 U 검정, 상관관계 분석을 실시하였다. ApoE ɛ4가 없는 경우에 CDR 1점과 2점에서 우울과 언어적 즉시회상 기억력이 유의한 음의 상관관계가 있었고(p<.05), ApoE ɛ4를 보유한 경우에는 CDR 1점에서 우울과 언어적 즉시회상, 언어적 지연회상 기억력에서 유의한 음의 상관관계가 있었다(p<.05). 우울과 언어적 즉시회상 기억력은 유의한 상관관계가 있었고 ApoE ɛ4를 보유한 경우에는 우울과 언어적 지연회상 기억력에도 유의한 상관관계가 있었다. 따라서 알츠하이머 치매의 예방 및 중재로 시각적인 훈련보다 언어적 기억력훈련이 유용할 것이며 우울치료가 상호보완적으로 도움을 줄 수 있을 것으로 기대한다.

• 대한한의학회지
• /
• 제27권2호
• /
• pp.96-102
• /
• 2006

Background & Purpose : Acupuncture with aromatherapy (AA) is a branch of complementary or alternative therapy recently growing in use. As the use of aromatherapy itself has grown so rapidly in recent years, studies about its safety have been accumulating. However, safety of AA has not been studied clinically and the treatment method which has the needles inserted after spreading essential oils exposes the human body more directly to components than aromatherapy. Therefore, we examined the safety of AA on patients treated thereby and physicians practising it. Methods : We observed all inpatients treated with AA from November 21, 2005 to March 31, 2006, in Kyung Hee Oriental Medical Center. During treatment, we monitored all of the newly developed signs from the patients to assess the adverse effects of AA. The patients' and physicians' general characteristics (gender, age, present illness, and treatment days) were obtained from medical records and analyzed to assess the clinical safety of AA in detail. Results : There were 440 patients treated with AA; clinical adverse effects appeared in 3 of them, which can be assessed as 0.7%. The major symptom was chest discomfort and choking originated from smell aversion condition (2 patients), and the other adverse effect was sensation of itching and reddening. However, none of them seemed to have direct relation with AA. A total of eight physicians applied AA and there were no symptoms related to it among them. Conclusions : We suggest that our results will contribute to confirming the safety of AA by offering clinical evidence.

• Journal of Gastric Cancer
• /
• 제8권3호
• /
• pp.120-128
• /
• 2008

목적: 여러 암 치료의 보조 및 대체요법으로서 겨우살이 추출물은 주로 유럽지역에서 이십세기 초부터 널리 사용되었고 현재 국내에서도 항암 대체 치료제로 점차 사용하는 추세이나 그 항암 기전은 아직 명확하게 밝혀져 있지 않다. 본 연구는 겨우살이 추출물이 위암에 미치는 영향을 세포주 실험을 통해 규명하였다. 대상 및 방법: 위암 세포주는 SNU-719 세포주를 사용하였고 처리한 겨우살이 추출물은 (주)한국 아브노바사로부터 제공받은 ABNOBAviscum-Q와 ABNOBAviscum-F 두 가지를 사용하였다. 겨우살이 추출물과 함께 처리한 항암제는 5-FU와 Cisplatin을 사용하였다. CCK-8 assay kit를 사용하여 세포 생존율을 측정하였고 젖산탈수소효소(LDH) assay kit로써 세포 사멸률을 측정하였다. Caspase 3 assay kit를 이용하여 세포자멸사에 관여하는 caspase 3의 활성 변화를 알아보았고 Western blot analysis를 통해 세포자멸사에 관여하는 Bcl2와 p53, 그리고 항암 작용을 하는 PTEN의 단백질 발현량을 측정하였다. 결과: 겨우살이 추출물 Q와 F를 각각 단독 처리한 실험군 보다 항암제인 5-FU와 cisplatin을 병합처리 하였을 때 세포생존율은 더 낮아졌다. Caspase 3의 활성은 겨우살이 추출물 및 항암제 5-FU 처리를 함으로써 대조군에 비해 4~6배 까지 증가하였다. Bcl2의 단백질 발현량은 대조군보다 겨우살이 추출물과 항암제 처리를 통해 감소하였고 두 약물을 함께 처리하였을 경우 더 낮아졌다. p53의 발현은 겨우살이 추출물 처리에는 영향을 받지 않았고 항암제 처리를 통해서만 증가되었다. 또한 항암 작용을 하는 PTEN의 단백질 발현 정도는 겨우살이 추출물 처리를 통해서 의미 있는 변화가 없었다. 결론: 겨우살이 추출물과 항암제인 5-FU 및 cisplatin 등을 병합 처리 할 경우 위암 세포 사멸에 있어 상승효과를 보였다. 본 연구결과에서 겨우살이 추출물의 항암효과는 caspase 3의 활성화와 Bcl2 발현의 감소를 통해 세포자멸사를 유발하며 이 세포자멸사 유도 기전은 p53과는 상관없음(p53-independent)을 알 수 있었다.

• 한국발생생물학회지:발생과생식
• /
• 제14권3호
• /
• pp.199-205
• /
• 2010

A neurotoxin, 6-hydroxydopamine (6-OHDA) has been widely used to create animal model for Parkinson's disease (PD). The present study was undertaken to examine whether depletion of brain dopamine (DA) stores with 6-OHDA can make alteration in the activities of the testicular steroidogenesis in adult rats. Young adult male rats (3 months old) were received a single dose of 6-OHDA (200 ${\mu}g$ in 10 ${\mu}{\ell}$/animal) by intracerebroventricular (icv) injection, and sacrificed after two weeks. The mRNA levels of steroidogenesis-related enzymes were measured by qRT-PCRs. Serum testosterone levels were measured by radioimmunoassay. Single icv infusion of 6-OHDA significantly decreased the mRNA levels of CYP11A1 (control:6-OHDA group=$1:0.68{\pm}0.14$ AU, p<0.05), CYP17 (control:6-OHDA group=$1:0.72{\pm}0.13$ AU, p<0.05). There were no changes in the mRNA levels of $3{\beta}$-HSD (control:6-OHDA group=$1:0.84{\pm}0.08$ AU) and $17{\beta}$-HSD (control: 6-OHDA group=$1:0.63{\pm}0.20$ AU), though the levels tended to be decreased in the 6-OHDA treated group. Administration of 6-OHDA decreased significantly the mRNA level of StAR when compared to the level of saline-injected control animals (control:6-OHDA group=$1:0.72{\pm}0.08$ AU, p<0.05). Treatment with single dose of 6-OHDA remarkably lowered serum testosterone levels compared to the levels of control group (control:6-OHDA group=$0.72{\pm}0.24:0.13{\pm}0.03ng/m{\ell}$, p<0.05). Taken together with our previous study, the present study demonstrated that the activities of hypothalamus-pituitary-testis hormonal axis could be negatively affected by blockade of brain DA biosynthesis, and suggested the reduced reproductive potential might be resulted in the animals. More precise information on the testicular steroidogenic activities in PD patients and PD-like animals should be required prior to the generalization of the sex steroid hormone therapy to meet the highest standards for safety and efficacy.